Challenges in the management of haemophilia on transition from adolescence to adulthood-Reference-Cited by-同舟云学术

Challenges in the management of haemophilia on transition from adolescence to adulthood

Published:2015-12 Issue: Volume:95 Page:30-35
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Brand Brigitte¹,Dunn Spencer²,Kulkarni Roshni³

Affiliation:

1. Division of Hematology; University Hospital Zürich; Zürich Switzerland

2. Center for Inherited Blood Disorders; Orange CA USA

3. Department of Pediatrics and Human Development; Michigan State University; Center for Bleeding and Clotting Disorders; East Lansing MI USA

Funder

Novo Nordisk Health Care AG, Zurich, Switzerland

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12582/fullpdf

Reference30 articles.

1. National Hemophilia Association Transition guidelines for people with bleeding disorders 2014 https://www.hemophilia.org/Researchers-Healthcare-Providers/Medical-and-Scientific-Advisory-Council-MASAC/All-MASAC-Recommendations/Transition-Guidelines-for-People-with-Bleeding-Disorders

2. Towards comprehensive care in transition for young people with haemophilia;Breakey;Haemophilia,2010

3. Wu J Purves P Breakey VR Creighton K Transitions toward independence All About Hemophilia: A Guide for Families 2nd edn http://www.hemophilia.ca/files/Chapter%2013.pdf

4. From boy to man: recommendations for the transition process in haemophilia;Young;Haemophilia,2012

5. Transition of care from paediatric to adult services in haematology;Bolton-Maggs;Arch Dis Child,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Teenagers and Adolescents with Hemophilia–Need for a Specific Approach;Journal of Clinical Medicine;2024-08-29

2. Normalisation of Haemostasis in Haemophilia A;EMJ Hematology;2024-07-25

3. Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12–<18 Years at Enrolment into PROTECT VIII;Acta Haematologica;2024-04-23

4. Primary prophylaxis implementation and long‐term joint outcomes in Swedish haemophilia A patients;Haemophilia;2024-04-04

5. A post hoc analysis of PROTECT VIII kids assessing long‐term efficacy and safety of damoctocog alfa pegol in adolescents with severe haemophilia A;European Journal of Haematology;2024-01-09